scholarly journals A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC ‐3197) and adalimumab (Humira) in patients with rheumatoid arthritis

2015 ◽  
Vol 19 (11) ◽  
pp. 1157-1168 ◽  
Author(s):  
Rajendrakumar H. Jani ◽  
Rajiv Gupta ◽  
Girish Bhatia ◽  
Gaurav Rathi ◽  
Patnala Ashok Kumar ◽  
...  
2010 ◽  
Vol 50 (10) ◽  
pp. 1171-1179 ◽  
Author(s):  
Shinichi Kawai ◽  
Eiji Uchida ◽  
Masakazu Kondo ◽  
Syuji Ohno ◽  
Junichi Obata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document